BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/2/2015 12:24:00 PM | Browse: 1610 | Download: 1753
 |
Received |
|
2013-12-31 08:56 |
 |
Peer-Review Started |
|
2013-12-31 09:38 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2014-03-04 21:03 |
 |
Revised |
|
2014-03-26 03:59 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-06-03 16:16 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-06-03 16:30 |
 |
Articles in Press |
|
2014-06-03 16:52 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-08-11 08:40 |
 |
Publish the Manuscript Online |
|
2014-08-20 20:37 |
| Category |
Rheumatology |
| Manuscript Type |
Topic Highlights |
| Article Title |
Efficacy and safety of tofacitinib for treatment of rheumatoid arthritis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Lisa M Lundquist, Sabrina W Cole and Martha L Sikes |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Lisa M Lundquist, PharmD, BCPS, College of Health Professions, Mercer University, 3001 Mercer University Drive, Atlanta, GA 30341,
United States. lundquist_lm@mercer.edu
|
| Key Words |
Tofacitinib; Rheumatoid arthritis; Janus kinase inhibitor |
| Core Tip |
Tofacitinib, a Janus kinase inhibitor, is a targeted, synthetic, disease-modifying antirheumatic drug (DMARD) approved for the treatment of moderately to severely active rheumatoid arthritis in patients who have had an inadequate response to methotrexate. In numerous phase 2 and 3 trials, tofacitinib has proven to be safe and effective as monotherapy or in combination with methotrexate or other non-biologic DMARDs.
|
| Publish Date |
2014-08-20 20:37 |
| Citation |
Lundquist LM, Cole SW, Sikes ML. Efficacy and safety of tofacitinib for treatment of rheumatoid arthritis. World J Orthop 2014; 5(4): 504-511 |
| URL |
http://www.wjgnet.com/2218-5836/full/v5/i4/504.htm |
| DOI |
http://dx.doi.org/10.5312/wjo.v5.i4.504 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.